Beijing Kangerfu Pharmaceutical Company Limited

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial on the Treatment of Hypertensive Intracerebral Hemorrhage With Naoxuekang Dropping Pills	Cerebral Hemorrhage, Hypertensive, Cerebral Small Vessel Diseases, Intracranial Hemorrhage, Hypertensive, Intracranial Hemorrhages, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, vascular disorder	Not yet recruiting	Phase 2	2025-10-01		NCT07200921

Clinical trials